Stanford Biotechnology Group
Stanford Biotech Group Podcast
The Stanford Biotech Group Podcast is your front-row seat to the people shaping the future of the life sciences. Run by Stanford graduate and professional students across PhD, MD, MBA, and MS programs, we sit down with the scientists, founders, and investors driving biotech forward. Let's pulling back the curtain on the breakthroughs, bets, and big ideas redefining medicine!
Hvor kan du lytte?
Podcasts i appen Replaio Radio Kommer snartPodcasts kommer snart til appen. Installer nu, og vær den første til at se en helt ny tilgang til podcasts
Episoder
Who Owns the Discovery? Biotech Patents and AI with Julia Minitti 17.11.2026 40:36
What should you think about before sharing a discovery in a preprint, on a conference poster, or with a chatbot? Host Afi Tagnedji sits down with Julia Minitti, a Wilson Sonsini patent partner and former medicinal chemist, to talk about when to file a patent, what investors look for in a biotech startup’s intellectual property, and who gets credit when AI helps design a drug. Julia also shares wha...
The Future of Farming Is Biotech 02.11.2026 40:34
In this episode of the Stanford Biotech Group Podcast, our Co-VP of Communications, Mikaela Ribi, sits down with Tim Schnabel, founder and CEO of Switch Bioworks, a Stanford spinout engineering microbes to produce sustainable nitrogen fertilizer. Together, we explore his journey from PhD research to entrepreneurship, the challenges of translating scientific discoveries into practical solutions, an...
World-Class Science. But Where Are Australia’s Biotechs? 21.10.2026 20:14
Our guest is Dr. Bob Soh, a partner at Brandon Capital, Australia’s biggest life sciences venture capital firm. Bob talks with Rui Yip about why Australia’s strong research base hasn’t produced a bigger biotech industry, and why overseas biotechs often run their Phase 1 trials here. They also cover how veterans of big pharma are helping launch new companies, how the local pool of biotech venture c...
Inside TwoStep: From the Bench to the Term Sheet, and Now, the Clinic 13.05.2026 22:35
Caitlyn Miller, CEO and co-founder of TwoStep Therapeutics, joins the SBG podcast to discuss her Series A biotech's five-target peptide platform for solid tumors, the path from Stanford PhD to funded company, and what no one tells you about founding.
Lignende podcasts
Replaio er ikke podcastudgiver; programmernes navne, coverbilleder og lyd tilhører deres ophavsmænd og distribueres via offentlige RSS-feeds.